Trade Deal Takes Away Pharma’s Biologic Exclusivity And Promotes Drug Competition

The trade deal announced yesterday between the United States, Mexico and Canada takes away pharmaceutical companies’ 10-year exclusivity for biologics. In addition, the United States-Mexico-Canada Agreement (USMCA) undos three additional years of patent protection when drug companies submit paperwork about a new use of a drug.

Healthcare Finance News

Trade Deal Takes Away Pharma’s Biologic Exclusivity And Promotes Drug Competition

In New Milestone, The Majority Of U.S. Medical Students Are Now Women

OIG: Hospitals Received Over $500 Million In Excessive Outlier Payments Over Four Years

2 Things Hospital CEOs Should Know About Boeing’s Management Pre-737 Max Crisis

Current Health Closes $11.5M Funding Round To Scale Its AI Wearable And Patient Management Technology

“SOC 1, SOC 2, And SOC For Cybersecurity Risks— Who Needs And How to Use Them”

Nonprofit Hospitals Get Bump In Moody’s Ratings For 2020

Failure To Properly Report PHI Breach Triggers $2.175 Million Settlement

Physician Specialties With The Highest Salaries And The Biggest Pay Increases In 2019

White House Summons Feuding Health Officials For Counseling Session

Obamacare Back At The High Court — With Billions For Insurers On The Line

Managing Risk In A Hyper-Outsourcing World Requires Facilitating Good Vendor Relationships

Healthcare Cybersecurity Employee Training Best Practices For CIOs And CISOs

CMS Details Direct Contracting Model Options

Michael Dowling: When It Comes To Health Disparities, Gaps In Mental Health Treatment Are The Worst

Executive Of The Year: Larry Merlo, CVS Health

Ban On Surprise Medical Bills May Pass After All

MedPAC Proposes Scrapping ASC Payment Update

OIG Reports More Than $5 Billion In Expected Investigative Recoveries For FY 2019

Patients Intrigued By Digital Health Services, But Still Value Face-To-Face Interactions

10 Updates On Amazon’s Healthcare Push